HistoSonics announces results of Phase I liver tumor trial
ANN ARBOR–HistoSonics Inc., the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective Phase I clinical trial, conducted …